Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Feb;50(2):121-5.

Relevance of changes in adrenoceptor characteristics after terbutaline treatment

  • PMID: 6297336

Relevance of changes in adrenoceptor characteristics after terbutaline treatment

G K Terpstra et al. Ann Allergy. 1983 Feb.

Abstract

Rats were treated with terbutaline in order to specify the in vivo effects of beta 2-sympathicomimetic treatment in relation with desensitization phenomena on the level of pulmonary adrenoceptors. Maximal binding of 3H-dihydroalprenolol (3H-DHA) to lung membrane preparations, binding affinity and the relative amount of beta 2-adrenoceptors were used as parameters. These were established 1, 3, and 6 days after a 10 days terbutaline treatment and compared with control values. Ten days treatment did not cause significant changes in the parameters measured. However, maximal binding was enhanced 3 and 6 days after the last treatment, binding affinity was enhanced 3 days after the last treatment, while the relative amount of beta 2-adrenoceptors was diminished 1 and 6 days after termination of the treatment. When the amount of beta 2-adrenoceptors was calculated in terms of 3H-DHA binding, an increase could be shown 3 days after the last terbutaline treatment. Therefore the direct influence of the treatment on the beta-adrenoceptor population appeared to be small, dependent on the parameter used and probably not eliciting a functional desensitization.

PubMed Disclaimer